By Nascent Biotech Posted June 3, 2014 In 2011_ACS2014-06-032014-06-03http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 2011_ACS Recent PostsNascent Biotech to Begin Phase II Clinical Trials for Brain CancerBenzinga: Why NBIO is a Biotech Bargain Basement Deal with Underappreciated PotentialJournal of Clinical Oncology: Phase 1 study of pritumumab in brain cancer.Nascent Biotech Regains Worldwide Rights for Pritumumab
